This webinar explores the trends in PRO-related product labeling and highlights key observations. Knowing the trends and the lessons learned from this review of US product labeling will enable you to formulate better PRO labeling strategies.
Updates
RTI Health Solutions has joined a collaborative led by the Medical Device Innovation Consortium that will work with Parkinson’s patients to determine the benefit and risk tradeoffs they are willing to make for potential new therapies.
Data from a head-to-head trial showed that LDX is a cost-effective treatment option compared with atomoxetine in children and adolescents who have had an inadequate response to the currently recommended first-line stimulant treatment.